Browsing by Subject "Radiotherapy"
Now showing items 1-20 of 20
-
Implementation of 26 Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications
(2023)Purpose: In March 2020, a 1-week adjuvant breast radiotherapy schedule, 26 Gy in 5 fractions, was adopted to reduce the risk of COVID19 for staff and patients. This study quantifies acute toxicity rates and the effect ... -
Metastatic disease in head & neck oncology
(2020)The head and neck district represents one of the most frequent sites of cancer, and the percentage of metastases is very high in both loco-regional and distant areas. Prognosis refers to several factors: a) stage of disease; ... -
NCCP advice for medical professionals on acceptable dose fractionation during the novel coronavirus (COVID-19) pandemic
(Health Service ExecutiveIE, 2020-07-22) -
NCCP advice for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak
(Health Service ExecutiveIE, 2020-04-01) -
NCCP advice for medical professionals on the management of patients undergoing lung cancer radiotherapy in response to the current novel coronavirus COVID 19 pandemic
(Health Service ExecutiveIE, 2020-06-05) -
NCCP advice for medical professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic
(Health Service ExecutiveIE, 2020-06-30) -
NCCP advice for Medical Professionals on the management of patients with head and neck cancer undergoing radiotherapy in response to the COVID-19 pandemic
(Health Service ExecutiveIE, 2020-05-20) -
NCCP advice for Medical Professionals on the treatment of patients with CNS tumours with radiotherapy in response to the COVID-19 pandemic
(Health Service ExecutiveIE, 2020-05-08) -
NCCP advice on the management of patients undergoing radiation oncology treatment, in response to the current novel coronavirus (COVID-19) pandemic
(Health Service ExecutiveIE, 2020-07-01) -
NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) pandemic
(Health Service ExecutiveIE, 2020-04-22) -
Radiation and immunotherapy in upper gastrointestinal cancers: The current state of play
(2021)Radiotherapy remains one of the contemporary cornerstones of cancer treatment in the neoadjuvant, curative, adjuvant and palliative settings, either in isolation or as a multimodal approach. Moreover, recent advances in ... -
Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey.
(2014)Abstract Background The ESTRO Health Economics in Radiation Oncology (HERO) project has the overall aim to develop a knowledge base of the provision of radiotherapy in Europe and build a model for health economic ... -
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
(2021)Immune checkpoint blockade (ICB) has revolutionised the treatment of solid tumours, yet most patients do not derive a clinical benefit. Resistance to ICB is often contingent on the tumour microenvironment (TME) and modulating ... -
The role and treatment potential of natural killer T (NKT) cells in patients with upper gastrointestinal cancers
(Trinity College Dublin. School of Medicine. Discipline of Immunology, 2019)Oesophageal adenocarcinoma (OAC), squamous cell carcinoma (SSC) and gastric cancers (GAC), collectively cause over 1.3 million deaths worldwide reported in 2018. Current therapeutic regimens focus on chemo-radiotherapy ... -
Selective effects of radiotherapy on viability and function of invariant natural killer T cells in vitro
(2020)Background and purpose: Immunotherapies involving the adoptive transfer of ex vivo expanded autologous invariant natural killer (iNKT) cells are a potential option for cancer patients and are under investigation in clinical ... -
The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation.
(2020)Background: Only 10-30% of oesophageal and rectal adenocarcinoma patients treated with neoadjuvant chemoradiotherapy have a complete pathological response. Inflammatory and angiogenic mediators in the tumour microenvironment ... -
Understanding radiotherapy
(Irish Cancer SocietyIE, 2009) -
Understanding Radiotherapy : Caring for people with cancer
(Irish Cancer SocietyIE, 2015) -
Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma.
(2019)Oesophageal adenocarcinoma (OAC) is an exemplar model of obesity-associated cancer. Response to neoadjuvant chemoradiotherapy (NA CRT) is a clinical challenge. We examined if visceral adipose tissue and obesity ...